Dr. Sharon Orrange - July 16, 2018
Trulicity, Victoza, and Bydureon all belong to a newer class of non-insulin diabetes medications known as GLP-1 (glucagon-like peptide-1) receptor agonists that improve blood sugar control and may lead to weight loss. They were each approved by the FDA in the last decade, and increase how much insulin the pancreas makes in response to high glucose levels.
Which drug is the most effective?
Trulicity (dulaglutide), approved in 2014, is the newest out of these three drugs. See More
Benita Lee - June 22, 2018
As with other forms of coverage restrictions, insurance plans use quantity limits to ensure patient safety and control healthcare costs. Quantity limits define how much of a drug you can fill during a specific time period, but they can be a hassle. Here’s how to navigate your plan’s policies, so you can still get the medications you need.
How do quantity limits work?
Generally speaking, plans will review clinical and FDA literature to decide how much of a drug they will cover in a certain time period. See More
Tori Marsh - June 14, 2018
Brand drugs are expensive — this we already know, and prices seem to only be increasing. Of the 100 most-prescribed brand-name medications, those for diabetes, rheumatoid arthritis, and Crohn’s disease tend to be the most expensive. All of the drugs on this list are brand-only medications, meaning that there are no affordable generic alternatives available.
Additionally, it can be difficult for people to receive adequate insurance coverage for many of these drugs as they may be placed in more expensive, higher-tier formularies or have some other coverage restrictions. See More
Roni Shye - January 16, 2018
If you’ve ever been afraid to show up at your doctor’s office because you’ve been “bad” then this post is for YOU! You may think your doctor is “pushing medications on you” especially if you aren’t experiencing any symptoms of the condition they are treating you for. However, their reasoning is not without sound medical and professional judgment.
One of the many reasons you might receive a lecture about the importance of taking your medications is due to the progressive nature of many diseases if not properly treated. See More
Roni Shye - December 27, 2017
Not all injectable diabetes medications contain insulin. A newer class of medications used for people with type 2 diabetes are considered non-insulin injectables and include drugs like Byetta, Victoza, Bydureon, and Trulicity.
Recently the FDA approved, Ozempic, a new non-insulin injectable for people with type 2 diabetes.
What is Ozempic indicated for?
Ozempic is a medication to be used in addition to a healthy diet and exercise to improve blood sugar control in adults with type 2 diabetes. See More
Roni Shye - November 28, 2017
New medications used to treat type 1 and type 2 diabetes are popping up left and right. From 2013-2016 there have been 15 new oral and injectable medications approved for the treatment of diabetes alone.
What’s noteworthy about this class? There’s a possibility that we might see some oral GLP-1 inhibitors soon! This could mean no more painful injections. See More
Roni Shye - May 31, 2017
Back in July, the FDA approved Adlyxin for diabetes type 2, and it is now available in pharmacies!
When people think about injectable diabetes medications, the first thing that comes to mind tends to be insulin medications like Humalog (insulin lispro) or Lantus (insulin glargine). However, the FDA has been approving many new non-insulin products recently, like Victoza and Byetta, and now Adlyxin!
What is Adlyxin indicated for?
Roni Shye - December 13, 2016
As 2016 comes to a close, we have some news in the world of diabetes medications! The FDA has recently released Soliqua 100/33, a combination medication for the treatment of type 2 diabetes.
Type 2 diabetes can be very tricky and hard to control. Therefore, the discovery and approval of these new oral and injectable medications are important for healthcare providers and their patients.
What is Soliqua 100/33 indicated for?
Soliqua 100/33 is prescribed to improve glycemic control in adults with type 2 diabetes, in conjunction with diet and exercise. See More
Dr. Sharon Orrange - October 06, 2015
More than 29 million Americans have diabetes. That’s more than 10% of the US—and that number continues to rise. More than 1.7 million adults were diagnosed with diabetes in 2012 alone.
Fortunately, several new medications for diabetes have recently been approved—Toujeo (a new insulin product), Synjardy (a new combination of empagliflozin/metformin) and others. These new drugs provide several benefits such as fewer side effects or foolproof self-dosing with an insulin pen. See More